| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| rp174094-500μg | 500μg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,334.90 | |
| rp174094-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,334.90 |
| Product Name | galectin-3, CAS No.rp174094 |
|---|---|
| Grade | Moligand™ |
| Specifications & Purity | Moligand™ |
| CAS | rp174094 |
|---|
| 1. Henderson NC, Sethi T. (2009) The regulation of inflammation by galectin-3.. Immunol Rev, 230 (1): (160-71). [PMID:19594635] [10.1021/op500134e] |
| 2. de Boer RA, Voors AA, Muntendam P, van Gilst WH, van Veldhuisen DJ. (2009) Galectin-3: a novel mediator of heart failure development and progression.. Eur J Heart Fail, 11 (9): (811-7). [PMID:19648160] [10.1021/op500134e] |
| 3. Streetly MJ, Maharaj L, Joel S, Schey SA, Gribben JG, Cotter FE. (2010) GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death.. Blood, 115 (19): (3939-48). [PMID:20190189] [10.1021/op500134e] |
| 4. Delaine T, Collins P, MacKinnon A, Sharma G, Stegmayr J, Rajput VK, Mandal S, Cumpstey I, Larumbe A, Salameh BA et al.. (2016) Galectin-3-Binding Glycomimetics that Strongly Reduce Bleomycin-Induced Lung Fibrosis and Modulate Intracellular Glycan Recognition.. Chembiochem, 17 (18): (1759-70). [PMID:27356186] [10.1021/op500134e] |
| 5. Harazono Y, Kho DH, Balan V, Nakajima K, Zhang T, Hogan V, Raz A. (2014) Galectin-3 leads to attenuation of apoptosis through Bax heterodimerization in human thyroid carcinoma cells.. Oncotarget, 5 (20): (9992-10001). [PMID:25393982] [10.1021/op500134e] |
| 6. DeRoo EP, Wrobleski SK, Shea EM, Al-Khalil RK, Hawley AE, Henke PK, Myers DD Jr, Wakefield TW, Diaz JA. (2015) The role of galectin-3 and galectin-3-binding protein in venous thrombosis.. Blood, 125 (11): (1813-21). [PMID:25428218] [10.1021/op500134e] |
| 7. Nakajima K, Kho DH, Yanagawa T, Harazono Y, Hogan V, Chen W, Ali-Fehmi R, Mehra R, Raz A. (2016) Galectin-3 Cleavage Alters Bone Remodeling: Different Outcomes in Breast and Prostate Cancer Skeletal Metastasis.. Cancer Res, 76 (6): (1391-402). [PMID:26837763] [10.1021/op500134e] |
| 8. Sumida Y, Yoneda M. (2018) Current and future pharmacological therapies for NAFLD/NASH.. J Gastroenterol, 53 (3): (362-376). [PMID:29247356] [10.1021/op500134e] |
| 9. Chan YC, Lin HY, Tu Z, Kuo YH, Hsu SD, Lin CH. (2018) Dissecting the Structure-Activity Relationship of Galectin-Ligand Interactions.. Int J Mol Sci, 19 (2): (1755-70). [PMID:29382172] [10.3390/ijms19020392] |
